Cited by 24Cardiac Valve Diseases and TreatmentsProtease and Inhibitor MechanismsBone and Dental Protein Studies

MMP-12–Induced pro-osteogenic responses in human aortic valve interstitial cells

Open access
Deng, Xin-sheng, Meng, Xianzhong, Li, Fei, Venardos, Neil, Fullerton, David, Jaggers, James·2019·Journal of Surgical Research

Abstract

Background Calcific aortic valve disease (CAVD) is an age-related and slowly progressive valvular disorder. Overexpression of matrix metalloproteinase 12 (MMP-12) has been found in atherosclerosis, stiffed vascular tissue, and calcified aortic valves. We hypothesized that MMP-12 may induce the pro-osteogenic responses in human aortic valve interstitial cells (AVICs).Methods Human AVICs were isolated from normal and calcified aortic valves. Cells were treated with MMP-12. The pro-osteogenic marker Runt-related transcription factor 2 (RUNX-2), bone morphogenetic protein 2 (BMP-2), and alkaline phosphatase (ALP), as well as MMP-12-associated signaling molecules, were analyzed.Results Human calcified aortic valves expressed significantly higher MMP-12 than normal human aortic valves. MMP-12-induced the expression of RUNX-2, BMP-2, ALP, and calcium deposit formation. Suppression of MMP-12 by its inhibitor decreased the expression of RUNX-2, BMP-2, and ALP. MMP-12-induced osteogenic responses were associated with higher levels of phosphorylation of p38 mitogen-activated protein kinases (MAPK), low density lipoprotein-related protein 6 (LRP-6), and β-catenin signaling molecules. Calcified aortic valves exhibited markedly higher levels of LRP-6 and β-catenin levels. Inhibition of either p38 MAPK or LRP-6 attenuated MMP-12-induced expression of RUNX-2, BMP-2, and ALP. Suppression of p38 MAPK abrogated MMP-12-induced activation of LRP-6 and β-catenin signaling pathways.Conclusions MMP-12 induces pro-osteogenic responses in AVICs by activation of p38 MAPK-mediated LRP-6 and β-catenin signaling pathways. The study revealed that the potential role of MMP-12 in the pathogenesis of CAVD and therapeutically targeting MMP-12 may suppress the development of CAVD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jss.2018.09.005

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Deng, X.-S., Meng, X., Li, F., Venardos, N., Fullerton, D., & Jaggers, J.
Affiliations
  • Children's Hospital Colorado (US)
  • University of Colorado Anschutz (US)
Corresponding author
Jaggers, James
Venue
Journal of Surgical Research
Publisher
Elsevier BV
Published
2019-03
Volume
235
Pages
44-51
ISSN
0022-4804 (ISSN-L)
OpenAlex
W2896894415
Cited by
24
References
28
Citations by year
2026: 4 · 2025: 3 · 2024: 5 · 2023: 3 · 2022: 3 · 2021: 2 · 2020: 4
FWCI
1.14
Type
journal article
Language
en
Open access
Locations
  • Journal of Surgical Research (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institutes of Health,United States (RO1 HL106582)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
  • Health Sciences › Medicine › Rheumatology › Bone and Dental Protein Studies
Keywords
MMP-12, calcific aortic valve disease, aortic valve interstitial cells, osteogenic differentiation, Runx2, BMP-2, alkaline phosphatase, p38 MAPK, β-catenin signaling, valve calcification, MMP-12 inhibitors
MeSH terms
Aged, Aortic Valve, Aortic Valve Stenosis, Calcinosis, Cells, Cultured, Female, Humans, Male, Middle Aged, Osteogenesis, Signal Transduction, p38 Mitogen-Activated Protein Kinases, beta Catenin, Matrix Metalloproteinase 12, Bone Morphogenetic Protein 2, Low Density Lipoprotein Receptor-Related Protein-6

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review